Johnson & Johnson’s $7.5 Billion Registered Notes Offering

Cravath represented the underwriters, led by BofA Securities, J.P. Morgan Securities, Citigroup and Deutsche Bank Securities, in connection with the $7.5 billion registered notes offering of Johnson & Johnson, a company engaged in the research and development, manufacturing and sale of a broad range of products in the healthcare field. Proceeds of the offering will be used to finance the acquisition of Momenta Pharmaceuticals, Inc., by Johnson & Johnson and for general corporate purposes. The transaction closed on August 25, 2020.

The Cravath team included partner Craig F. Arcella and associate Saagar Kaul on capital markets matters, and associate Luis Calderon‑Gomez on tax matters. Bethany E. Clarke also worked on capital markets matters.